Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40007780
Localisation
India
Asia
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
27/02/2025
Statut
Classification
1.5°C
Année cible
FY2034
Statut
Targets set
Classification
1.5°C
Année cible
FY2050
Overall Net-Zero Target: Malladi Drugs & Pharmaceuticals Limited commits to reach net-zero greenhouse gas emissions across the value chain by FY2050. Near-Term Targets: Malladi Drugs & Pharmaceuticals Limited commits to reduce absolute scope 1 and 2 GHG emissions 58.8% by FY2034 from a FY2024 base year.* Malladi Drugs & Pharmaceuticals Limited also commits to reduce absolute scope 3 GHG emissions 58.8% within the same timeframe.* *The target boundary includes land-related emissions and removals from bioenergy feedstocks. Long-Term Targets: Malladi Drugs & Pharmaceuticals Limited commits to reduce absolute scope 1 and 2 GHG emissions 90% by FY2050 from a FY2024 base year.* Malladi Drugs & Pharmaceuticals Limited also commits to reduce absolute scope 3 GHG emissions 90% within the same timeframe.* *The target boundary includes land-related emissions and removals from bioenergy feedstocks.
Statut
Targets setAnnée cible
FY2050
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
ISIN
INE814G01013
LEI
3358002C1Y7LIKFL1661
Source : Science Based Targets initiative | Données publiques